EUVIMEDEUVIMED entdecken
Crossref

Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA

Bo Sun, Yimeng Wang, Ruyu Han, Yuren Xia, Meng Zhao, Liyu Sun, Xiaochen Ma, Tianqiang Song, Xiangdong Tian, Wenchen Gong, Lu Chen

BioScience Trends · 2025

DOI: 10.5582/bst.2025.01178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioScience Trends, 2025. Verfasst von Bo Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, National Key Laboratory of Druggability Evalu…. Hauptthemen laut MEDLINE: Liver Neoplasms, Cholangiocarcinoma, Carcinoma, Hepatocellular, Bile Duct Neoplasms. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCholangiocarcinomaCarcinoma, HepatocellularBile Duct NeoplasmsHumansChemotherapy, AdjuvantFemaleMiddle AgedMaleRetrospective StudiesPrognosisNomogramsAgedKaplan-Meier EstimateAdultLymphatic MetastasisPropensity Score

Stichwörter der Autor:innen

adjuvant chemotherapycHCC-CCAoverall survivalprognostic nomogrampropensity score matching

Autor:innen und Institutionen

  • Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Key Laboratory of…
  • The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Hepatobiliary Cancer, Liver cancer research center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Clinical laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Department of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Zitieren

APA

Sun, B., Wang, Y., Han, R., Xia, Y., Zhao, M., Sun, L., Ma, X., Song, T., Tian, X., Gong, W., & Chen, L. (2025). Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA. BioScience Trends. https://doi.org/10.5582/bst.2025.01178

Vancouver

Sun B, Wang Y, Han R, Xia Y, Zhao M, Sun L, et al. Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA. BioScience Trends. 2025. doi:10.5582/bst.2025.01178

BibTeX
@article{Sun2025,
  author = {Sun, Bo and Wang, Yimeng and Han, Ruyu and Xia, Yuren and Zhao, Meng and Sun, Liyu and Ma, Xiaochen and Song, Tianqiang and Tian, Xiangdong and Gong, Wenchen and Chen, Lu},
  title = {Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA},
  journal = {BioScience Trends},
  year = {2025},
  doi = {10.5582/bst.2025.01178}
}
Kostenlos starten →